Gene expression profiling analysis reveals decreased levels of HIF-1α and its target genes (including VEGF and hexokinase) in PD patients, with an upregulation of PHD2 in the SNpc homogenate of PD patients compared to age-matched controls. This evidence concerns the gene EGLN1 and Parkinson disease.